Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -3.21% | 137.71 | 0.0% | $884.02m | |
| AMGN | Amgen, Inc. | -0.57% | 243.96 | 1.5% | $794.57m | |
| GILD | Gilead Sciences, Inc. | 0.06% | 63.22 | 1.0% | $531.81m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -3.62% | 252.35 | 1.9% | $444.70m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.25% | 659.20 | 2.6% | $412.80m | |
| ILMN | Illumina, Inc. | -1.40% | 239.81 | 3.3% | $302.05m | |
| NVAX | Novavax, Inc. | 0.31% | 52.11 | 75.7% | $294.76m | |
| BIIB | Biogen, Inc. | -3.54% | 195.71 | 1.8% | $238.30m | |
| BNTX | BioNTech SE | -1.72% | 157.06 | 0.0% | $213.96m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -2.86% | 2.04 | 0.7% | $142.60m | |
| EXAS | EXACT Sciences Corp. | -3.90% | 52.00 | 17.7% | $139.49m | |
| NKTX | Nkarta, Inc. | -5.29% | 13.08 | 0.0% | $101.73m | |
| TECH | Bio-Techne Corp. | -3.22% | 359.09 | 4.5% | $98.14m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.19% | 78.18 | 4.2% | $97.71m | |
| TXG | 10X Genomics, Inc. | -4.31% | 47.33 | 0.0% | $92.15m |
Company Profile
22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.